PRT04 Long-Term Disease Stability with Antibody Monotherapies in Moderate-to-Severe Atopic Dermatitis
Fri, Mar 27, 12:45 PM - 1:30 PM
Exhibit Hall - Theater 2
Product Theater
DESCRIPTION
Gain insights into AD cytokine-driven pathophysiology, antibody monotherapy mechanisms of action, and efficacy/safety data supporting durable disease control across diverse patient populations.
Presented by: Lilly USA, LLC